Contact-dependent interference with invariant NKT cell activation by herpes simplex virus-infected cells

Journal of Immunology

Volumn 188, Issue 12, 2012, Pages 6216-6224

  Bosnjak, Lidija ^a   Sahlström, Peter ^a   Paquin Proulx, Dominic ^a   Leeansyah, Edwin ^a   Moll, Markus ^a   Sandberg, Johan K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; ECALECTIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 5; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE ZAP 70; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CONTACT; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HERPES SIMPLEX VIRUS 1; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KERATINOCYTE; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUPERNATANT; T LYMPHOCYTE ACTIVATION; TH1 CELL; UPREGULATION; VIRUS INTERFERENCE;

CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; HERPES SIMPLEX; HUMANS; KERATINOCYTES; LYMPHOCYTE ACTIVATION; NATURAL KILLER T-CELLS; SIMPLEXVIRUS;

EID: 84862627317     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100218     Document Type: Article

References (69)

1. Cunningham, A. L., R. R. Turner, A. C. Miller, M. F. Para, and T. C. Merigan. 1985. Evolution of recurrent herpes simplex lesions. An immunohistologic study. J. Clin. Invest. 75: 226-233. (Pubitemid 15171242)
2. Koelle, D. M., C. M. Posavad, G. R. Barnum, M. L. Johnson, J. M. Frank, and L. Corey. 1998. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Invest. 101: 1500-1508. (Pubitemid 28166848)
3. Ho, L. P., L. Denney, K. Luhn, D. Teoh, C. Clelland, and A. J. McMichael. 2008. Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection. Eur. J. Immunol. 38: 1913-1922.
4. Kakimi, K., L. G. Guidotti, Y. Koezuka, and F. V. Chisari. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192: 921-930.
5. Godfrey, D. I., D. G. Pellicci, O. Patel, L. Kjer-Nielsen, J. McCluskey, and J. Rossjohn. 2010. Antigen recognition by CD1d-restricted NKT T cell receptors. Semin. Immunol. 22: 61-67.
6. Chang, Y.-J., J.-R. Huang, Y.-C. Tsai, J.-T. Hung, D. Wu, M. Fujio, C.-H. Wong, and A. L. Yu. 2007. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids. Proc. Natl. Acad. Sci. USA 104: 10299-10304. (Pubitemid 47185659)
7. Van Kaer, L. 2005. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat. Rev. Immunol. 5: 31-42. (Pubitemid 40070329)
8. Kuylenstierna, C., N. K. Björkström, S. K. Andersson, P. Sahlström, L. Bosnjak, D. Paquin-Proulx, K. J. Malmberg, H. G. Ljunggren, M. Moll, and J. K. Sandberg. 2011. NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d. Eur. J. Immunol. 41: 1913-1923.
9. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, H. Sato, E. Kondo, M. Harada, H. Koseki, T. Nakayama, et al. 1998. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl. Acad. Sci. USA 95: 5690-5693. (Pubitemid 28224157)
10. Metelitsa, L. S., O. V. Naidenko, A. Kant, H. W. Wu, M. J. Loza, B. Perussia, M. Kronenberg, and R. C. Seeger. 2001. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J. Immunol. 167: 3114-3122. (Pubitemid 32852549)
11. Godfrey, D. I., S. Stankovic, and A. G. Baxter. 2010. Raising the NKT cell family. Nat. Immunol. 11: 197-206.
12. Carnaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, and A. Bendelac. 1999. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163: 4647-4650. (Pubitemid 29501223)
13. Eberl, G., and H. R. MacDonald. 2000. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30: 985-992. (Pubitemid 30216213)
14. Fujii, S.-I., K. Shimizu, C. Smith, L. Bonifaz, and R. M. Steinman. 2003. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198: 267-279. (Pubitemid 36987852)
15. Leite-de-Moraes, M. C., M. Lisbonne, A. Arnould, F. Machavoine, A. Herbelin, M. Dy, and E. Schneider. 2002. Ligand-activated natural killer T lymphocytes promptly produce IL-3 and GM-CSF in vivo: relevance to peripheral myeloid recruitment. Eur. J. Immunol. 32: 1897-1904. (Pubitemid 34814545)
16. Nieda, M., M. Okai, A. Tazbirkova, H. Lin, A. Yamaura, K. Ide, R. Abraham, T. Juji, D. J. Macfarlane, and A. J. Nicol. 2004. Therapeutic activation of Valpha24+ Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103: 383-389. (Pubitemid 38140063)
17. Diana, J., and A. Lehuen. 2009. NKT cells: friend or foe during viral infections? Eur. J. Immunol. 39: 3283-3291.
18. Tupin, E., Y. Kinjo, and M. Kronenberg. 2007. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 5: 405-417. (Pubitemid 46780078)
19. Kinjo, Y., E. Tupin, D. Wu, M. Fujio, R. Garcia-Navarro, M. R.-E.-I. Benhnia, D. M. Zajonc, G. Ben-Menachem, G. D. Ainge, G. F. Painter, et al. 2006. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7: 978-986. (Pubitemid 44263912)
20. Kinjo, Y., D. Wu, G. Kim, G.-W. Xing, M. A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C.-H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525. (Pubitemid 40477061)
21. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu, III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529. (Pubitemid 40477062)
22. Kronenberg, M., and Y. Kinjo. 2009. Innate-like recognition of microbes by invariant natural killer T cells. Curr. Opin. Immunol. 21: 391-396.
23. Lind, S. M., C. Kuylenstierna, M. Moll, E. D Jordö, O. Winqvist, L. Lundeberg, M. A. Karlsson, M. T Linder, C. Johansson, A. Scheynius, et al. 2009. IL-18 skews the invariant NKT-cell population via autoreactive activation in atopic eczema. Eur. J. Immunol. 39: 2293-2301.
24. Brigl, M., R. V. V. Tatituri, G. F. M. Watts, V. Bhowruth, E. A. Leadbetter, N. Barton, N. R. Cohen, F.-F. Hsu, G. S. Besra, and M. B. Brenner. 2011. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J. Exp. Med. 208: 1163-1177.
25. Tyznik, A. J., E. Tupin, N. A. Nagarajan, M. J. Her, C. A. Benedict, and M. Kronenberg. 2008. Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J. Immunol. 181: 4452-4456.
26. Wang, X., X. Chen, L. Rodenkirch, W. Simonson, S. Wernimont, R. M. Ndonye, N. Veerapen, D. Gibson, A. R. Howell, G. S. Besra, et al. 2008. Natural killer T-cell autoreactivity leads to a specialized activation state. Blood 112: 4128-4138.
27. Ashkar, A. A., and K. L. Rosenthal. 2003. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77: 10168-10171. (Pubitemid 37122101)
28. Cantin, E., B. Tanamachi, and H. Openshaw. 1999. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J. Virol. 73: 3418-3423. (Pubitemid 29135735)
29. Milligan, G. N., and D. I. Bernstein. 1997. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 229: 259-268. (Pubitemid 27243509)
30. Yu, Z., E. Manickan, and B. T. Rouse. 1996. Role of interferon-gamma in immunity to herpes simplex virus. J. Leukoc. Biol. 60: 528-532. (Pubitemid 26356779)
31. Grubor-Bauk, B., J. L. Arthur, and G. Mayrhofer. 2008. Importance of NKT cells in resistance to herpes simplex virus, fate of virus-infected neurons, and level of latency in mice. J. Virol. 82: 11073-11083.
32. Grubor-Bauk, B., A. Simmons, G. Mayrhofer, and P. G. Speck. 2003. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant Valpha 14-J alpha 281 TCR. J. Immunol. 170: 1430-1434. (Pubitemid 36139511)
33. Cornish, A. L., R. Keating, K. Kyparissoudis, M. J. Smyth, F. R. Carbone, and D. I. Godfrey. 2006. NKT cells are not critical for HSV-1 disease resolution. Immunol. Cell Biol. 84: 13-19.
34. Yuan, W., A. Dasgupta, and P. Cresswell. 2006. Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nat. Immunol. 7: 835-842. (Pubitemid 44084090)
35. Raftery, M. J., F. Winau, S. H. E. Kaufmann, U. E. Schaible, and G. Schönrich. 2006. CD1 antigen presentation by human dendritic cells as a target for herpes simplex virus immune evasion. J. Immunol. 177: 6207-6214. (Pubitemid 44628839)
36. Rao, P., H. T. Pham, A. Kulkarni, Y. Yang, X. Liu, D. M. Knipe, P. Cresswell, and W. Yuan. 2011. Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function. J. Virol. 85: 8093-8104.
37. Chen, N., C. McCarthy, H. Drakesmith, D. Li, V. Cerundolo, A. J. McMichael, G. R. Screaton, and X.-N. Xu. 2006. HIV-1 down-regulates the expression of CD1d via Nef. Eur. J. Immunol. 36: 278-286. (Pubitemid 43257450)
38. Moll, M., S. K. Andersson, A. Smed-Sörensen, and J. K. Sandberg. 2010. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood 116: 1876-1884.
39. Sanchez, D. J., J. E. Gumperz, and D. Ganem. 2005. Regulation of CD1d expression and function by a herpesvirus infection. J. Clin. Invest. 115: 1369-1378. (Pubitemid 40629057)
40. Webb, T. J. R., R. A. Litavecz, M. A. Khan, W. Du, J. Gervay-Hague, G. J. Renukaradhya, and R. R. Brutkiewicz. 2006. Inhibition of CD1d1-mediated antigen presentation by the vaccinia virus B1R and H5R molecules. Eur. J. Immunol. 36: 2595-2600. (Pubitemid 44608443)
41. Zhao, Y., R. Fishelevich, J. P. Petrali, L. Zheng, M. A. Anatolievna, A. Deng, R. L. Eckert, and A. A. Gaspari. 2008. Activation of keratinocyte protein kinase C zeta in psoriasis plaques. J. Invest. Dermatol. 128: 2190-2197.
42. Bonish, B., D. Jullien, Y. Dutronc, B. B. Huang, R. Modlin, F. M. Spada, S. A. Porcelli, and B. J. Nickoloff. 2000. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. J. Immunol. 165: 4076-4085. (Pubitemid 32057319)
43. Han, J.-Y., S. A. Miller, T. M. Wolfe, H. Pourhassan, and K. R. Jerome. 2009. Cell type-specific induction and inhibition of apoptosis by herpes simplex virus type 2 ICP10. J. Virol. 83: 2765-2769.
44. Ito, M., M. Watanabe, H. Kamiya, and M. Sakurai. 1997. Herpes simplex virus type 1 induces apoptosis in peripheral blood T lymphocytes. J. Infect. Dis. 175: 1220-1224. (Pubitemid 27176515)
45. Braun, R. W., H. K. Teute, H. Kirchner, and K. Munk. 1984. Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell. J. Immunol. 132: 914-919. (Pubitemid 14189117)
46. Hastings, W. D., D. E. Anderson, N. Kassam, K. Koguchi, E. A. Greenfield, S. C. Kent, X. X. Zheng, T. B. Strom, D. A. Hafler, and V. K. Kuchroo. 2009. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur. J. Immunol. 39: 2492-2501.
47. Khademi, M., Z. Illés, A. W. Gielen, M. Marta, N. Takazawa, C. Baecher-Allan, L. Brundin, J. Hannerz, C. Martin, R. A. Harris, et al. 2004. T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluidderived mononuclear cells in multiple sclerosis. J. Immunol. 172: 7169-7176. (Pubitemid 38669161)
48. Zhu, C., A. C. Anderson, A. Schubart, H. Xiong, J. Imitola, S. J. Khoury, X. X. Zheng, T. B. Strom, and V. K. Kuchroo. 2005. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6: 1245-1252. (Pubitemid 43045636)
49. Jones, R. B., L. C. Ndhlovu, J. D. Barbour, P. M. Sheth, A. R. Jha, B. R. Long, J. C. Wong, M. Satkunarajah, M. Schweneker, J. M. Chapman, et al. 2008. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205: 2763-2779.
50. Klibi, J., T. Niki, A. Riedel, C. Pioche-Durieu, S. Souquere, E. Rubinstein, S. Le Moulec, J. Guigay, M. Hirashima, F. Guemira, et al. 2009. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 113: 1957-1966.
51. Dumont, F. J., M. J. Staruch, P. Fischer, C. DaSilva, and R. Camacho. 1998. Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J. Immunol. 160: 2579-2589. (Pubitemid 28136707)
52. Egerton, M., D. R. Fitzpatrick, A. D. Catling, and A. Kelso. 1996. Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway. Eur. J. Immunol. 26: 2279-2285. (Pubitemid 26340924)
53. Egerton, M., D. R. Fitzpatrick, and A. Kelso. 1998. Activation of the extracellular signal-regulated kinase pathway is differentially required for TCR-stimulated production of six cytokines in primary T lymphocytes. Int. Immunol. 10: 223-229. (Pubitemid 28085372)
54. Koelle, D. M., and L. Corey. 2003. Recent progress in herpes simplex virus immunobiology and vaccine research. Clin. Microbiol. Rev. 16: 96-113. (Pubitemid 36114709)
55. Sloan, D. D., and K. R. Jerome. 2007. Herpes simplex virus remodels T-cell receptor signaling, resulting in p38-dependent selective synthesis of interleukin-10. J. Virol. 81: 12504-12514. (Pubitemid 350085864)
56. Biswas, S. K., and A. Mantovani. 2010. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11: 889-896.
57. Malmgaard, L., and S. R. Paludan. 2003. Interferon (IFN)-alpha/beta, interleukin (IL)-12 and IL-18 coordinately induce production of IFN-gamma during infection with herpes simplex virus type 2. J. Gen. Virol. 84: 2497-2500. (Pubitemid 37063139)
58. Carr, J. A., J. Rogerson, M. J. Mulqueen, N. A. Roberts, and R. F. Booth. 1997. Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections. J. Virol. 71: 7799-7803. (Pubitemid 27391726)
59. Mikloska, Z., V. A. Danis, S. Adams, A. R. Lloyd, D. L. Adrian, and A. L. Cunningham. 1998. In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions - do herpes simplex virus-infected keratinocytes contribute to their production? J. Infect. Dis. 177: 827-838. (Pubitemid 28155133)
60. Sloan, D. D., J.-Y. Han, T. K. Sandifer, M. Stewart, A. J. Hinz, M. Yoon, D. C. Johnson, P. G. Spear, and K. R. Jerome. 2006. Inhibition of TCR signaling by herpes simplex virus. J. Immunol. 176: 1825-1833. (Pubitemid 43134327)
61. Griffith, C. E., W. Zhang, and R. L. Wange. 1998. ZAP-70-dependent and -independent activation of Erk in Jurkat T cells. Differences in signaling induced by H2o2 and Cd3 cross-linking. J. Biol. Chem. 273: 10771-10776. (Pubitemid 28227694)
62. Shan, X., R. Balakir, G. Criado, J. S. Wood, M. C. Seminario, J. Madrenas, and R. L. Wange. 2001. Zap-70-independent Ca(2+) mobilization and Erk activation in Jurkat T cells in response to T-cell antigen receptor ligation. Mol. Cell. Biol. 21: 7137-7149. (Pubitemid 32953468)
63. Golden-Mason, L., B. E. Palmer, N. Kassam, L. Townshend-Bulson, S. Livingston, B. J. McMahon, N. Castelblanco, V. Kuchroo, D. R. Gretch, and H. R. Rosen. 2009. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J. Virol. 83: 9122-9130.
64. Sehrawat, S., P. B. J. Reddy, N. Rajasagi, A. Suryawanshi, M. Hirashima, and B. T. Rouse. 2010. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog. 6: e1000882.
65. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354. (Pubitemid 44435155)
66. Moll, M., C. Kuylenstierna, V. D. Gonzalez, S. K. Andersson, L. Bosnjak, A. Sönnerborg, M. F. Quigley, and J. K. Sandberg. 2009. Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infection. Eur. J. Immunol. 39: 902-911.
67. Trautmann, L., L. Janbazian, N. Chomont, E. A. Said, S. Gimmig, B. Bessette, M.-R. Boulassel, E. Delwart, H. Sepulveda, R. S. Balderas, et al. 2006. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202. (Pubitemid 44527357)
68. Im, J. S., P. Arora, G. Bricard, A. Molano, M. M. Venkataswamy, I. Baine, E. S. Jerud, M. F. Goldberg, A. Baena, K. O. A. Yu, et al. 2009. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation. Immunity 30: 888-898.
69. Lindqvist, M., J. Persson, K. Thörn, and A. M. Harandi. 2009. The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection. J. Immunol. 182: 6435-6443.